How can we trick the immune system into overcoming the detrimental effects of oncolytic viral therapy to treat glioblastoma?

Expert Rev Neurother. 2013 Apr;13(4):341-3. doi: 10.1586/ern.13.25.
No abstract available

Publication types

  • Editorial
  • Review

MeSH terms

  • Brain Neoplasms / immunology*
  • Brain Neoplasms / therapy*
  • Glioblastoma / immunology*
  • Glioblastoma / therapy*
  • Humans
  • Oncolytic Virotherapy / adverse effects*